Genmab — August 2018
-
Ikke kun GM smager markedsmekanismerne efter positivt regnskab...Sølv Søren: "Jeg forventer en lille stigning i aktien, som afspejler et bedre end ventet regnskab. Men heller ikke meget mere end det.." og Lundbecks CFO "Det, vi har leveret i dag, er super flot"...markedet?..8-10% ned!
-
@mollegade Og i artikelen ("Genmabtopchef: Darzalex' salg kan accelerere væsentligt") fra april i Børsen giver direktør Winkel en fin overflyning på Darzalex' markedsposition/hovedtriggere de kommende par år: http://borsen.dk/nyheder/virksomheder/artikel/1/361103/genmabtopchef_darzalex_salg_kan_accelerere_vaesentligt.html
-
Og her en fin lille artikel om Darzalex' salgsdudvikling fra juli i Børsen efter 2Q salgstallene kom fra JNJ http://borsen.dk/nyheder/virksomheder/artikel/1/365823/salget_af_genmabs_guldaeg_overgaar_alle_forventninger.
html -
-
Morphosys kører videre med deres kinesiske partner I-mab: https://finance.yahoo.com/n
ews/dgap-news-morphosys-mab-biopharma-011500009.html -
DGAP-News: MorphoSys and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202
NASDAQ: MOR) and I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biologics in oncology and autoimmune diseases, announced today that I-Mab has submitted an investigational new drug (IND) application to China National Drug Administration (CNDA) for TJ202/MOR202, a human monoclonal antibody directed against CD38 for the treatment of multiple myeloma. Multiple myeloma is the second most common blood cancer worldwide. The patient number has gradually increased in China in recent years due to an increasingly aging population.
Yahoo Finance (finance.yahoo.com)
-
Kan jeg stille spørgsmål til Q & A her: What is the status for the subcutan version of Darzalex? And what is the status for darzalex in rheumatological diseases?
-
Hvorfor ikke direkte i Q&A chatten lige nu?
-
Du melder dig til her. http://www.proinvestor.com/index.php?p=q-and-a&groupid=92
-
Derefter kan du stille spørgsmålet i Q&A chatten. Den finder du i drop down boxen.
-
Jeg prøver der
-
Tak Tandfe...Spørgsmålet er gået ind.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind